Cocrystal Pharma, Inc.
corporate_fare Company Profile
Cocrystal Pharma, Inc. (NASDAQ:COCP) is a publicly traded company in the Life Sciences sector. Wiseek monitors COCP SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Cocrystal Pharma Appoints Biopharma Veteran James Sapirstein as New CEO
- Cocrystal Pharma Appoints Biopharma Veteran James Sapirstein as New CEO
- Cocrystal Pharma Cuts Co-CEO Salaries by 40% Amidst Going Concern Warning; Grants New Equity Options
- Cocrystal Pharma Discovers Pan-Viral Inhibitors for Hantavirus, Bunyavirus, and Influenza
- Cocrystal Pharma Discovers Pan-Viral Inhibitors for Hantavirus, Bunyavirus, and Influenza
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for COCP, detected from its recent SEC filings · based on capital-structure filings through 2026-05-15.
Going Concern Warning Reiterated · Limited Cash Runway
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →